pomalidomide
NPI-0052-107
Phase 1 small_molecule completed
Quick answer
pomalidomide for Multiple Myeloma in Relapse is a Phase 1 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Multiple Myeloma in Relapse
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed